iShares U.S. Healthcare ETF (IYH)
| Assets | $3.03B |
| Expense Ratio | 0.39% |
| PE Ratio | 30.66 |
| Shares Out | 52.35M |
| Dividend (ttm) | $0.73 |
| Dividend Yield | 1.25% |
| Ex-Dividend Date | Dec 17, 2024 |
| Payout Ratio | 37.60% |
| 1-Year Return | +2.80% |
| Volume | 513,171 |
| Open | 58.07 |
| Previous Close | 57.55 |
| Day's Range | 58.01 - 58.80 |
| 52-Week Low | 56.44 |
| 52-Week High | 66.59 |
| Beta | 0.68 |
| Holdings | 110 |
| Inception Date | Jun 12, 2000 |
About IYH
Fund Home PageThe iShares U.S. Healthcare ETF (IYH) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a cap-weighted index of pharmaceutical, biotechnology, health care services and equipment companies in the US. IYH was launched on Jun 12, 2000 and is issued by BlackRock.
Top 10 Holdings
54.13% of assets| Name | Symbol | Weight |
|---|---|---|
| Eli Lilly and Company | LLY | 11.72% |
| UnitedHealth Group Incorporated | UNH | 8.40% |
| Johnson & Johnson | JNJ | 6.64% |
| AbbVie Inc. | ABBV | 5.84% |
| Merck & Co., Inc. | MRK | 4.77% |
| Thermo Fisher Scientific Inc. | TMO | 3.80% |
| Abbott Laboratories | ABT | 3.68% |
| Intuitive Surgical, Inc. | ISRG | 3.62% |
| Danaher Corporation | DHR | 2.83% |
| Pfizer Inc. | PFE | 2.82% |
Dividends
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 17, 2024 | $0.200 | n/a |
| Sep 25, 2024 | $0.234 | Sep 30, 2024 |
| Jun 11, 2024 | $0.126 | Jun 17, 2024 |
| Mar 21, 2024 | $0.167 | Mar 27, 2024 |
| Dec 20, 2023 | $0.1778 | Dec 27, 2023 |
| Sep 26, 2023 | $0.234 | Oct 2, 2023 |
News
Final Trades: Disney, Ashtead Group, Trade Desk and the IYH
The Investment Committee give you their top stocks to watch for the second half.
IYH: Healthcare Dashboard For October
This monthly report analyzes key industry metrics in the healthcare sector. This sector is overvalued by about 20% relative to 11-year averages. Healthcare providers are the least overvalued subsector...
Final Trades: John Deere, Copart, Amgen and the IYH
The Investment Committee give you their top stocks to watch for the second half.
Final Trades: KKR & Co, Leidos Holdings, Abbvie, and the IYH
The Investment Committee give you their top stocks to watch for the second half.
Final Trades: Interactive Brokers, Delta, the SMIN and IYH
The Investment Committee give you their top stocks to watch for the second half.
IYH: Strong Performance Expected In The Next Few Years
IYH invests in large-cap U.S. healthcare stocks with strong earnings growth potential. Despite trailing the S&P 500 index in the past year, healthcare stocks are expected to rebound strongly in 2024 a...
IYH: How Another Smaller, Equally-Weighted Competitor May Outperform
iShares U.S. Healthcare ETF is a hold due to high valuations, increased competition, and macroeconomic factors.
Final Trades: JNJ, M, IYH & CLF
The final trades of the day with CNBC's Melissa Lee and the Fast Money traders.
Final Trades: Target, Las Vegas Sands, Apollo Global and the IYH
The Investment Committee share their top stocks in the second half.
IYH: Healthcare Dashboard For January
The healthcare sector is overvalued by 12.5% based on 11-year averages. Nevertheless, the healthcare providers industry shows a good value score. iShares U.S. Healthcare ETF is an unattractive alterna...
Healthcare In 2024: Navigating The Biopharma Bull Run
The healthcare sector presents a unique investment opportunity in 2024 due to attractive valuation and uncorrelated/robust cashflow of healthcare. Biopharma companies have pricing power and ability to...
IYH: Good Way To Gain Exposure To The Healthcare Sector
iShares U.S. Healthcare ETF provides exposure to the healthcare sector, holding 120 healthcare-related stocks. Healthcare stocks have had varying performances in recent years, with winners and losers ...
Final Trades: Shake Shack, Pfizer, Humana and iShares US Healthcare
The 'Halftime Report' traders give their top picks to watch for.
Fundamentals for M&A in healthcare sector remain really strong, says Guggenheim's Mehta
Punit Mehta, Guggenheim Securities head of healthcare investment banking, joins 'Squawk on the Street' to discuss the healthcare M&A market, how Mehta sees the growth of the new class of weight-loss d...
IYH: Long-Term Growth Outlook Not As Bright As Before
iShares U.S. Healthcare ETF is not recommended for long-term holding due to diminished long-term earnings growth and rich valuation. IYH has better downside protection than the S&P 500 index and has p...
IYH: Healthcare Dashboard For July
Pharmaceuticals/biotechnology is the most attractive subsector regarding both value and quality scores. Healthcare equipment is the most overpriced healthcare industry. Fast facts on iShares U.S. Heal...
IYH: Focus On Pharmaceutical And Managed Healthcare Stocks Is Paying-Off
IYH bets on stocks of companies engaged in the business of pharmaceutical and managed healthcare - two sectors that have relatively stable price growth. Healthcare expenditure holds up in times of det...
Government shutdown fears are growing. Here's what to watch, and when to expect trouble.
Fresh off the debt-ceiling showdown, Washington may be looking at another fiscal crisis: a government shutdown.
IYH: Even During A Recession, Folks Want To Stay Healthy (Rating Upgrade)
IYH: Even During A Recession, Folks Want To Stay Healthy (Rating Upgrade).
IYH: Destiny's Favorite Child
Healthcare is a defensive sector that enjoys major secular tailwinds. It is a veritable freight train when you look at the aging demographic trends that are estimated worldwide. IYH exhibits low volat...
IYH: Healthcare Stocks Will Likely Outperform In The New Year
As most of you know, a high inflation and rising interest rate environment favors defensive sectors that typically outperform in recessionary periods. Healthcare is one such sector. This year, the iSh...
IYH And IHI ETFs: These 2 Healthcare/Medical Funds Compliment Each Other
The iShares U.S. Healthcare ETF (IYH) seeks to track the investment results of the Russell 1000 Health Care RIC 22.5/45 Capped Index composed of U.S. equities. The iShares U.S. Medical Devices ETF (IH...